Achillion Pharmaceuticals
(NASDAQ: ACHN) is developing iron nanoparticle-based therapeutics. The company’s lead product, Feraheme, has been approved by the FDA for the treatment of iron deficiency anemia in adult patients with chronic kidney disease.
Aclaris Therapeutics
Aclaris Therapeutics (NASDAQ: ACRS) is a specialty pharmaceutical company focused on the development of novel dermatological therapies.
Actelion Pharmaceuticals
Actelion is part of the Johnson & Johnson Family of Companies. We are leaders in the science and medicine of pulmonary arterial hypertension (PAH), with more than 15 years of experience in this chronic and progressive disease.
Acura Pharmaceuticals
Acura Pharmaceuticals is a specialty pharmaceutical company engaged in research, development and manufacture of innovative Aversion® (abuse deterrent) Technology and related product candidates.
Advanced Accelerator Applications
AAA (acquired by Novartis) is an innovative medicines company focused on the development of products for targeted radioligand therapy and precision radioligand imaging.
Agile Therapeutics
Agile Therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women.
Aimmune Therapeutics
Aimmune is a clinical-stage biopharmaceutical company developing proprietary product candidates and advancing a therapeutic approach for the treatment of peanut and other food allergies.
AirXpanders
AirXpanders (ASX: AXP) is a medical device company that has developed the AeroForm tissue expander.
Akari Therapeutics
Akari Therapeutics, Plc (Nasdaq: AKTX), a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases
Aligos Therapeutics
Aligos is developing targeted, curative therapies for hepatologic diseases and viral infections, including chronic hepatitis B virus, non-alcoholic steatohepatitis and hepatocellular carcinoma.
Apellis Pharmaceuticals
Apellis Pharmaceuticals (NASDAQ: APLS) is a clinical stage biopharmaceutical company focused on the discovery and development of novel therapeutic compounds for autoimmune and inflammatory diseases.
Ascendis Pharma
Ascendis Pharma (NASDAQ: ASND) develops differentiated prodrug versions of high-value drugs.
Aurinia Pharmaceuticals
Aurinia is a clinical stage biopharmaceutical company focused on developing and commercializing therapies in disease areas of high unmet medical need.
Avanir Pharmaceuticals
Avanir Pharmaceuticals (NASDAQ: AVNR) is focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases.
Biohaven Pharmaceutical
Biohaven Pharma (NASDAQ: BHVN) is a publicly held biopharmaceutical company engaged in the identification and development of clinical stage compounds targeting orphan neurologic indications and other neurological pathways.
Biotie Therapies
Biotie Therapies (NASDAQ: BITI) is a specialized drug development company focused on products for neurodegenerative and psychiatric disorders. Acquired by Acorda.
Bolt biotherapeutics
Bolt Biotherapeutics is developing its novel Boltbody™ platform for cancer immunotherapy therapy that consists of Immune-Stimulating Antibody Conjugates (ISAC).
Ceptaris Therapeutics
Ceptaris Therapeutics (acquired by Actelion) is a privately held specialty pharmaceutical company developing a product for the treatment of cutaneous T-cell lymphoma (CTCL)
ChemoCentryx
ChemoCentryx is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer, primarily focused on orphan and rare diseases.
CoLucid Pharmaceuticals
CoLucid Pharmaceuticals is a biotechnology company focusing on therapies for central nervous system disorders.
Crinetics Pharmaceuticals
Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
CRISPR Therapeutics
CRISPR Therapeutics is a world leader in CRISPR Cas9 gene editing technology.
Cubist Pharmaceuticals
Cubist Pharmaceuticals was an American biopharmaceutical company with activities spanning from research and development to commercialization of pharmaceutical products.
Durata Therapeutics
Durata Therapeutics (NASDAQ: DRTX) is a pharmaceutical company focused on the development and commercialization of therapeutic solutions in infectious disease.
Dynavax Technologies
Dynavax Technologies (NASDAQ: DVAX) is a clinical-stage biopharmaceutical company committed to discovering and developing novel products to prevent and treat infectious diseases.
Foamix Pharmaceuticals
Foamix is working to solve some of today’s most difficult therapeutic challenges. With every problem we take on, our approach is the same: question traditional assumptions and find a better solution.
Genetron Health
Genetron Health offers full-cycle cancer molecular diagnostics products and services from prevention to treatment. They are also dedicated to cancer genomics research and provide comprehensive cancer-related cooperation solutions for researchers and medical institutions worldwide.
German Medical Technologies
German Medical Technologies is a growth-stage medical device company focused on developing, manufacturing, and marketing medical consumables.
Golden Stapler Surgical
Golden Stapler Surgical Co.Ltd was established in 2007,who dedicates itself to provide optimal surgical products word-widely.
Haier Bio-Medical
Haier Bio-Medical designs, manufactures, and markets biomedical and laboratory equipment for the global market.
Harmony Biosciences
Harmony Biosciences is an innovative biopharmaceutical company dedicated to identifying, developing, and commercializing novel treatment options for patients with rare diseases.
Hunan Jingfeng Pharmaceutical
The Company produces and sells chemical medicine, biological medicine, traditional Chinese medicine, and other related products.
Impel Neuropharma
Impel NeuroPharma is using its Precision Olfactory Delivery (POD) nasal devices to develop therapies for diseases of the brain such as migraine and Alzheimer’s.
InnoCare Pharma
InnoCare is a biopharmaceutical company in China with the global vision to discover and develop novel treatment for cancer and autoimmune diseases.
Intellia Therapeutics
Intellia is revolutionizing medicine by harnessing the power of genome editing to develop potential cures.
Kala Pharmaceuticals
Kala is a company developing novel therapies to treat serious eye conditions.
KalVista Pharmaceuticals
KalVista Pharmaceuticals (NASDAQ: KALV) is creating a new generation of small molecule protease inhibitors.
Kanghui Medical
KangHui Medical (NYSE: KH) was a leading Chinese orthopedic device manufacturer with products in trauma, spine, and joint reconstruction. Acquired by Medtronic for $816m.
Kite Pharma
Kite, a Gilead company, is dedicated to achieving one of the most ambitious goals of 21st century medicine: curing cancer. This mission is at the heart of everythingwe do, from early research to product development
Lee’s Pharmaceuticals
Lee’s Pharmaceuticals is a fully-integrated specialty pharmaceuticals company focused on the China market, with a product portfolio spanning cardiovascular care, infectious disease, dermatology, ophthalmology, oncology, and gynecology.
Medeor Therapeutics
Medeor Therapeutics is a private, late clinical stage, biotechnology company dedicated to the discovery, development, and commercialization of transformative and personalized cellular immunotherapies.
Medley Health
A technology-driven healthcare services company, Medley Health is committed to redefining the doctor-patient relationship in order to achieve high quality, cost-effective primary and preventative health care.
Menlo Therapeutics
Menlo Therapeutics (NASDAQ: MNLO) is a clinical stage biopharmaceutical company focused on the treatment of chronic itch and chronic refractory cough.
Minerva Neurosciences
Minerva Neurosciences, Inc. (NASDAQ: NERV) is a clinical-stage biopharmaceutical company focused on the development of a portfolio of product candidates to treat central nervous system (CNS) diseases.
Minerva Surgical
Minerva Surgical is developing next-generation technology for treating excessive menstrual bleeding.
Nabriva Therapeutics
Nabriva (NASDAQ: NBRV) is an anti-infective company developing a novel therapy for Community Acquired Pneumonia.
Neomend
NeoMend, Inc. (acquired by Bard) is a medical device company commercializing ProGel Pleural Air Leak Sealant for lung air leaks. The company has a proprietary platform technology which seals and facilitates healing of soft tissue wounds caused by trauma or surgical procedures.
Nexcida Therapeutics
Nexcida, a Frazier Healthcare Partners portfolio company, is developing novel antibiotics to treat serious, life-threatening bacterial infections.
Nora Therapeutics
Nora Therapeutics is a specialty biopharmaceutical company developing therapeutics to address clinical unmet needs in reproductive medicine.
Ocera Therapeutics
Ocera Therapeutics (NASDAQ: OCRX) is a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for patients with acute and chronic liver disease, an area of high unmet clinical need.
OncoGenex Pharmaceuticals
OncoGenex Pharmaceuticals (NASDAQ: OGXI) is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address treatment resistance in cancer patients.
Outpost Medicine
Outpost Medicine is developing a novel therapy for overactive bladder and irritable bowel syndrome.
Passage Bio
Passage Bio is a genetic medicines company developing therapies for the treatment of rare monogenic central nervous system diseases
Poseida Therapeutics
Poseida Therapeutics is a clinical-stage biopharmaceutical company leveraging our proprietary next-generation, non-viral gene engineering technologies to create life-saving cell therapeutics for patients with high unmet medical need.
PrinJohnson BioPharm
PrinJohnson BioPharm focuses on the development and sale of generic pharmaceuticals.
REGENXBIO
REGENXBIO (NASDAQ: RGNX) is a gene therapy platform company that is leveraging its proprietary NAV® Technology to advance the development of life-changing adeno-associated viral (AAV) treatments for lysosomal storage disorders, ocular diseases, and other unmet clinical needs.
Rempex Pharmaceuticals
Rempex Pharmaceuticals (Acquired by The Medicines Company) is a pharmaceutical company focused on the discovery and development of new antibacterial drugs to treat multi-drug resistant bacterial pathogens.
River Vision Development
River Vision Development Corporation researches and develops protein therapies. The Company provides its products for the treatment of graves' orbitopathy.
Sagent Pharmaceuticals
Sagent Pharmaceuticals (NASDAQ: SGNT) is an international specialty injectable pharmaceutical company bringing finished pharmaceutical products to the U.S. market. Acquired by Nichi-Iko Pharmaceutical Co., Ltd.
SciClone Pharmaceuticals
SciClone Pharmaceuticals (NASDAQ: SCLN) is a revenue-generating, specialty pharmaceutical company with a substantial commercial business in China and a product portfolio spanning oncology, infectious disease, and cardiovascular markets.
Selecta Biosciences
Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company that is focused on unlocking the full potential of biologic therapies by mitigating unwanted immune responses.
Semnur Pharmaceuticals
Semnur Pharmaceuticals is a pharmaceutical company developing an injectable product for the treatment of lower back pain.
SentreHeart
SentreHEART is a commercial stage medical device company with a novel suture delivery and tissue closure device for multiple clinical applications.
Shanghai Hile Biopharmaceuticals
Shanghai Hile (SHA: 603718) is a leading manufacturer of animal vaccines in China.
Shanghai Sundise
Shanghai Sundise Traditional Chinese Medicine Co., Ltd. is a leading high-technology corporation specialized in the modernization of Traditional Chinese Medicine (TCM).
Sierra Oncology
Sierra Oncology (NASDAQ: SRRA) is a clinical stage drug development company advancing next generation DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer.
SinoMedCare Biotech
SinoMedCare Biotech is a leading, innovation-driven pharmaceutical distribution platform.
Sinovac Biotech
Sinovac Biotech Ltd. is a Chinese based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases.
Soleno Therapeutics
Soleno Therapeutics, Inc. is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases.
Strongbridge Biopharma
Strongbridge Biopharma plc (NASDAQ: SBBP) is a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs.
Sunesis Pharmaceuticals
Sunesis is a clinical-stage biopharmaceutical company focused on the development and commercialization of new oncology therapeutics.
Surgical Specialties
Surgical Specialties is a medical device company that is marketing surgical products on a worldwide basis.
Suzhou Omni Pharmaceutical
Suzhou Pharmaceutical Group Co. Ltd. manufactures and distributes pharmaceutical products. The Company produces antibiotics, estrogenic agents, nonsteroidal anti-inflammatory agents, antipyretic analgesics, and other medical products.
Suzhou Yichuan
Company specializes in research & development of health products delivery system, especially nasal products delivery system.
Swift Health Systems
Swift Health Systems is a diverse team of bone biologists, computer scientists, engineers, designers, and orthodontists that are inspired to impact the lives of hundreds of millions of people worldwide.
Synapse Biomedical
Synapse Biomedical (SBI) is dedicated to the research, development and commercialization of life-altering neurostimulation products.
Synaptic Medical
Synaptic Medical is a leading player in cardiac EP ablation in China.
Terns Pharmaceuticals
Terns Pharmaceuticals is a global biopharmaceutical company committed to discovering and developing molecularly-targeted, oral, small molecule drugs to treat liver diseases and cancers.
Tianyin Pharmaceuticals
Tianyin Pharmaceutical was set up in 1994 and now is based in Cheng Du, China. The company focuses on biopharmaceutical medicines, famous for its generics, traditional Chinese medicines.
Tokai Pharmaceuticals
Tokai Pharmaceuticals (NASDAQ: TKAI), based in Boston, Massachusetts, is focused on translating innovative science to develop and deliver innovative therapies that provide hope and healing for patients living with cancer.
TOT Biopharm
TOT Biopharm is a biopharmaceutical enterprise dedicated to developing, manufacturing, and commercializing oncology drugs.
TRIA Beauty
TRIA Beauty is a leader in light-based therapeutic beauty systems that incorporate clinically-proven aesthetic technologies for at-home personal care regimens.
Verona Pharma
Verona Pharma plc is a clinical stage biopharmaceutical company focused on the development and commercialization of innovative prescription medicines to treat respiratory diseases with significant unmet medical needs, such as COPD, cystic fibrosis and asthma.
Vicept Therapeutics
Vicept Therapeutics is developing novel products for the treatment of rosacea and other dermatological conditions. Acquired by Allergan.
Viropharma
ViroPharma Incorporated was a pharmaceutical company that developed and sold drugs that addressed serious diseases treated by physician specialists and in hospital settings. Acquired by Shire
VISEN Pharma
VISEN Pharma – Developing and commercializing TransCon hGH, TransCon PTH, and TransCon CNP for the Greater China market.
Yestar International
Yestar International (HK: 2393) is a diversified company with a position in imaging and in vitro diagnostics.
YM Bioscience
YM BioSciences (NYSE: YMI) is a pharmaceutical company advancing a diverse portfolio of promising hematology and cancer-related products at various stages of development. Acquired by Gilead Sciences.
Zosano Pharma
Zosano Pharma Corporation is a clinical-stage biopharmaceutical company focused on providing systemic administration of therapeutics to patients using our proprietary Adhesive Dermally-Applied Microneedle, or ADAM technology.